Yichang

DGAP-News: ​​​​​​​PAION ANNOUNCES THAT NMPA ACCEPTS SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BESYLATE IN GENERAL ANESTHESIA BY CHINESE LICENSEE YICHANG HUMANWELL

Retrieved on: 
星期五, 七月 9, 2021

Aachen (Germany), 09 July 2021 - The specialty pharma company PAION AG (PA8; ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard) today announces that its Chinese remimazolam licensee Yichang Humanwell informed PAION that the National Medical Products Administration (NMPA) has accepted their New Drug Application (NDA) for remimazolam besylate in general anesthesia for review.

Key Points: 
  • Aachen (Germany), 09 July 2021 - The specialty pharma company PAION AG (PA8; ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard) today announces that its Chinese remimazolam licensee Yichang Humanwell informed PAION that the National Medical Products Administration (NMPA) has accepted their New Drug Application (NDA) for remimazolam besylate in general anesthesia for review.
  • Yichang Humanwell recently successfully completed the clinical development for remimazolam besylate in general anesthesia.
  • Dr. Jim Phillips, CEO of PAION AG, commented: "Yichang Humanwell has already made great progress in the China market with Ruima(R) (remimazolam besylate) in procedural sedation, exceeding our initial expectations.
  • Remimazolam besylate (brand name Ruima(R)) was approved in China for procedural sedation during colonoscopy in July 2020.

Strong Momentum in Tianyun International's Development in Central China Yichang Tiantong Achieves Record Performance

Retrieved on: 
星期三, 六月 2, 2021

The Group therefore allotted and issued 13,050,000 ordinary shares to Long Advance Investments Limited ("Long Advance Investments") as Consideration Shares.

Key Points: 
  • The Group therefore allotted and issued 13,050,000 ordinary shares to Long Advance Investments Limited ("Long Advance Investments") as Consideration Shares.
  • The completion of the acquisition of Yichang Tiantong has strengthened the future development of the Group.
  • These demonstrate strategic significance for the Group to explore the market in the central part of the PRC with its own brand."
  • In addition, the Group's project in Yuan'an County, Yichang City, will form a synergistic effect with Yichang Tiantong and effectively increase the production capacity of beverages and other products.

China's Yichang Invites Global Tourists

Retrieved on: 
星期二, 四月 13, 2021

One seventh of the pianos in the world are "made in Yichang" every year.\nThe Chinese custom of making zongzi to commemorate Qu Yuan on the Dragon Boat Festival every year originated from Yichang.

Key Points: 
  • One seventh of the pianos in the world are "made in Yichang" every year.\nThe Chinese custom of making zongzi to commemorate Qu Yuan on the Dragon Boat Festival every year originated from Yichang.
  • Major cuisines blend with each other here, and Yichang people are eclectic, forming Yichang Bachu cuisine with delicate flavor and spicy flavor.
  • Tourists can enjoy the Tujia hand waving dance, an ancient dance popular with the Tujia ethnic group.
  • Eight RV camps distributed in key areas are welcoming self-driving tourists from all over the country.

DGAP-News: PAION ANNOUNCES PROGRESS WITH REMIMAZOLAM BY ITS PARTNER YICHANG HUMANWELL IN CHINA

Retrieved on: 
星期二, 八月 11, 2020

Aachen (Germany), 11 August 2020 - The Specialty Pharma Company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard: PA8) today announces that its Chinese remimazolam licensee Yichang Humanwell has recently launched Ruima(R) (remimazolam) in procedural sedation in China.

Key Points: 
  • Aachen (Germany), 11 August 2020 - The Specialty Pharma Company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard: PA8) today announces that its Chinese remimazolam licensee Yichang Humanwell has recently launched Ruima(R) (remimazolam) in procedural sedation in China.
  • Remimazolam (brand name Ruima(R)) was approved in China for procedural sedation in July 2020.
  • We are delighted by the strong commitment to remimazolam by our Chinese partner Yichang Humanwell.
  • In China, licensee Yichang Humanwell received market approval in procedural sedation in July 2020.

"Falling In Love With Yichang" was organized by the Yangtze

Retrieved on: 
星期一, 九月 16, 2019

YICHANG, China, Sept. 16, 2019 /PRNewswire/ -- A tourism marketing activity themed on "Falling In Love With Yichang" was organized from Sept. 7 to 9 in the beautiful central Chinese city by the Yangtze.

Key Points: 
  • YICHANG, China, Sept. 16, 2019 /PRNewswire/ -- A tourism marketing activity themed on "Falling In Love With Yichang" was organized from Sept. 7 to 9 in the beautiful central Chinese city by the Yangtze.
  • On Sept. 8, they visited the Gezhou Dam, Xiling Gorge and Three Gorges Dam on a cruise ship.
  • Samuel Robert from Australia said it was the best way to take a ship to appreciate the sight of the Three Gorges.
  • "I will promote the city when I go back home, and let more Koreans to come to visit Yichang."

"Falling In Love With Yichang" was organized by the Yangtze

Retrieved on: 
星期一, 九月 16, 2019

YICHANG, China, Sept. 16, 2019 /PRNewswire/ -- A tourism marketing activity themed on "Falling In Love With Yichang" was organized from Sept. 7 to 9 in the beautiful central Chinese city by the Yangtze.

Key Points: 
  • YICHANG, China, Sept. 16, 2019 /PRNewswire/ -- A tourism marketing activity themed on "Falling In Love With Yichang" was organized from Sept. 7 to 9 in the beautiful central Chinese city by the Yangtze.
  • On Sept. 8, they visited the Gezhou Dam, Xiling Gorge and Three Gorges Dam on a cruise ship.
  • After getting off the ship, they took a bus to have a closer look at the world's largest water conservation project.
  • "I will promote the city when I go back home, and let more Koreans to come to visit Yichang."